Response to IL17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding and untranslated regions of the IL17A gene: results from a multicentre study of four European psoriasis cohorts

van Vugt LJ, van den Reek JMPA, Meulewaeter E, Hakobjan M, Heddes N, Traks T, Kingo K, Galluzzo M, Talamonti M, Lambert J, Coenen MJH, de Jong EMGJ. (2019). Response to IL17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding and untranslated regions of the IL17A gene: results from a multicentre study of four European psoriasis cohorts. Journal of the European Academy of Dermatology and Venereology : JEADV.10.1111/jdv.15787 [ilmumas].
ajakirjaartikkel
van Vugt LJ, van den Reek JMPA, Meulewaeter E, Hakobjan M, Heddes N, Traks T, Kingo K, Galluzzo M, Talamonti M, Lambert J, Coenen MJH, de Jong EMGJ.
  • Inglise
Journal of the European Academy of Dermatology and Venereology : JEADV
1468-3083
2019
Ilmumas
1.1. Teadusartiklid, mis on kajastatud Web of Science andmebaasides Science Citation Index Expanded, Social Sciences Citation Index, Arts & Humanities Citation Index ja/või andmebaasis Scopus (v.a. kogumikud)
WOS

Viited terviktekstile

doi.org/10.1111/jdv.15787

Lisainfo